Integrium, LLC

Submit Your Questions or RFP

Reach Out
+1 (714) 541-5591
  • Home
  • About Us
    • Our Team
    • Our Founding Partners
    • Mission Statement
    • How We Can Help You
    • Quick Turnaround
    • Careers
  • Services
    • CV Core Lab
    • Biostatistics and Statistical Programming
    • Data Management
    • Drug Safety and Medical Monitoring
    • Medical Writing
    • Planning and Feasibility
    • Project Management
    • Site Monitoring
    • Study Design and Protocol Development
    • Study Start-Up Services
    • Consulting Services
    • Patient Recruitment
  • Our Expertise
    • Cardiovascular
    • Dermatology
    • Metabolic
    • Pain
    • Renal
    • Miscellaneous
      • Central Nervous System
      • Healthy Patient Experience
      • Hepatology
      • Nephrology
      • Oncology
      • Orphan Disease
      • Regenerative Medicine
      • Respiratory
      • Urology
      • Women’s Health
      • Wound Healing
    • Ethnobridging
    • Generics & Biosimilars
    • Microbiome
  • News & Media
    • Newsletter – The Integrium Researcher
    • News/Press Releases
    • Blog – A Dose of Drug Development
    • Media
  • Calendar
    • Current Events
    • Featured event
  • Contact Us

Phase I/II Study for Essential Hypertension Screening Performed On Time

June 29th, 2016 Integrium Uncategorized

By: Emily MacHale
June 29, 2016

Tustin, CA – Integrium Clinical Research announced their on time screening goal completion for their phase I/II study for essential hypertension, with a total of 52 patients. The screenings were completed on two separate days within a two-week time frame, implementing 22 screenings on the first day and 30 screenings on the second day.

Read more

Integrium, LLC would like to welcome Greg to the Business Development team!

June 14th, 2016 Integrium Uncategorized

Greg’s role at Integrium is Senior Director, Business Development, with a focus in late phase clinical trials.

Greg’s favorite food is Chinese, specifically dim sum, and one of the many places he has traveled to is China! A fun fact about Greg is that he has a relative degree of fluency in Cantonese and he lived in Hong Kong for two years.

Read more

How to Mind the Gap in Ethnobridging Clinical Trials

June 6th, 2016 Integrium Uncategorized

By Emily MacHale
June 6, 2016

Why are Ethnobridging clinical trials so vital in the biopharmaceutical industry today? Global companies are consistently collecting Japanese, Chinese, Taiwanese, and Korean early phase data in clinical development to fulfill specific goals.

Read more

Categories

  • Blog Posts
  • Uncategorized

Recent Posts

  • Integrium, LLC Executives to attend Oppenheimer & Co. 29th Annual Healthcare Conference (New York)
  • Integrium, LLC Executives to attend Oncology Investor Conference (Boston)
  • Integrium, LLC Executives to attend BIO CEO & Investor Conference
  • Integrium, LLC Executives to Attend 37th Annual J.P. Morgan Healthcare Conference San Francisco, CA
  • Integrium, LLC Executives to Attend LD Micro 11th Annual Event Bel-Air, CA

Archives

  • March 2019
  • February 2019
  • November 2018
  • September 2018
  • August 2018
  • May 2018
  • November 2017
  • October 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • October 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • July 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2014
  • January 2014
  • May 2013

How can we help you?

Contact us to learn more about how we can assist, we would be delighted to discuss the possibilities with you!

1-877-332-1572

Let us know what you need help with

Reach out

Integrium, LLC

14351 Myford Road
Tustin, CA 92780
Phone: +1 (714) 541-5591
Toll Free: (877) 332-1572

Navigation

  • Home
  • About Us
  • Our Services
  • Contact Us

Connect with us and we’ll connect you

©2023 Integrium, LLC All Rights Reserved.
  • Privacy Policy
  • Website by Pronto